Status:

COMPLETED

Angioplasty in Peripheral Arterial Disease and Endothelial Function

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Collaborating Sponsors:

Swiss Heart Foundation

Conditions:

Peripheral Arterial Obstructive Disease

Intermittent Claudication

Eligibility:

All Genders

40-90 years

Phase:

PHASE4

Brief Summary

To investigate whether endovascular revascualrization of infrainguinal arterial obstructive disease has an effect on brachial artery reactivity

Detailed Description

Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis affecting a large proportion of the aged population. It is associated with a more or less severe impairment in functional...

Eligibility Criteria

Inclusion

  • Peripheral arterial disease
  • femoro-popliteal lesion
  • successful endovascular treatment of lesion

Exclusion

  • persistent claudication after revascularization in arm A
  • inflammatory or neoplastic disease
  • pregnancy

Key Trial Info

Start Date :

December 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT00660634

Start Date

December 1 2004

End Date

April 1 2008

Last Update

April 28 2008

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.